📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice. (2022)

First Author: Stavrou M

Attributed to: Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci159814

PubMed Identifier: 35579942

Publication URI: http://europepmc.org/abstract/MED/35579942

Type: Journal Article/Review

Volume: 132

Parent Publication: The Journal of clinical investigation

Issue: 13

ISSN: 0021-9738